You have to be signed in to use this resource.
S04 E152 - Episode 152: Potential antibiotics: lolamicin
Episode notes
Season 4 is here! Tune in for the first episode. Luis talks to Dr. Paul Hergenrother about lolamicin. Dr. Hergenrother is a Professor of Chemistry at the University of Illinois in Urnaba-Champaign. He was previously a guest in the podcast (fabimycin episode) and this time he returns to talk about another potential antibiotic candidate: lolamicin. What is lolamicin? What is the mechanism of action? What organisms does it have activity against? Does it affect the gut microbiota?
Link to Dr. Hergenrother's article:https://www.nature.com/articles/s41586-024-07502-0
Questions? Feedback? Send those toletstalkmicro@outlook.com
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 30 August 2024 |
| Audience access level: | General user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.